Veeva Systems VEEV recently announced that Amgen AMGN has selected its Vault CRM for a global deployment, extending a collaboration that has spanned more than a decade. The rollout is expected to ...

The proposed takeover gives Amgen rare disease drug Tavneos, which last fall became ChemoCentryx’s first commercial product in its 25-year history. (Amgen) Facing one of the biopharma industry’s ...

Hospira’s motion to dismiss Count I of Amgen’s complaint has been denied, and Amgen will be able to seek declaratory judgment relief in the form of an injunction requiring Hospira to comply with the ...

The last two years were not marked by big successes for Amgen. The performance of products and candidates gained through the $28 billion acquisition of Horizon Therapeutics back in 2023 was far from ...

Today, in the AbbVie v. Amgen adalumimab case, Judge Robinson entered a stipulated order that dismissed Count XI of AbbVie’s Complaint. With its Count XI, AbbVie sought an order compelling Amgen to ...

Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.